JEFFREY M LEIDEN

CIK 1242825 · Executive Chairman · last filed 2026-05-11

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$16.90M

Companies

4

Total Filings

106

Lifetime Open-Market Net

-$544.74M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ODTX Director 298,896 $100.0K 1 2026-05-11
VRTX Executive Chairman 35,237 $444.93 $15.68M -$543.95M 88 2026-02-26
DGX Director 6,000 $203.06 $1.22M -$890.2K 15 2018-05-30
MILLENNIUM PHARMACEUTICALS INC (MLNM) Delisted Director $0 2 2008-05-15

Recent Filings · Page 8 of 11

106 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2016-05-19 DGX Grant (A) +2,196 $0 EDGAR
2016-02-04 VRTX Mixed +43,983 -$892.6K EDGAR
2016-01-14 VRTX Gift (G) $0 EDGAR
2016-01-06 DGX Grant (A) $0 EDGAR
2015-11-20 VRTX Sell (S) −16,125 -$2.10M EDGAR
2015-11-03 VRTX Sell (S) −16,125 -$2.02M EDGAR
2015-10-05 DGX Grant (A) $0 EDGAR
2015-07-23 VRTX Grant (A) $0 EDGAR
2015-07-02 DGX Grant (A) $0 EDGAR
2015-06-01 DGX Grant (A) +2,340 $0 EDGAR
Showing 7180 of 106
Page 8 of 11
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.